|
DOLPP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.256600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.932400E-01 |
| Normal-vs-Stage2 |
2.815400E-01 |
| Normal-vs-Stage3 |
9.522200E-01 |
| Normal-vs-Stage4 |
4.005000E-01 |
| Stage1-vs-Stage2 |
5.113800E-01 |
| Stage1-vs-Stage3 |
3.014600E-01 |
| Stage1-vs-Stage4 |
1.001420E-01 |
| Stage2-vs-Stage3 |
2.349400E-01 |
| Stage2-vs-Stage4 |
8.807500E-02 |
| Stage3-vs-Stage4 |
3.890200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.817600E-01 |
| Normal-vs-AfricanAmerican |
5.636200E-01 |
| Normal-vs-Asian |
2.970200E-01 |
| Caucasian-vs-AfricanAmerican |
4.413000E-01 |
| Caucasian-vs-Asian |
3.141000E-01 |
| AfricanAmerican-vs-Asian |
1.604580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.658800E-01 |
| Normal-vs-Female |
6.501000E-01 |
| Male-vs-Female |
8.408200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.105800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.978000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.685800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.461800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.523800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.582400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.370200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.838200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.695600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.215600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.359650E-01 |
| Classical-VS-Follicular |
8.346200E-01 |
| Classical-VS-Other |
4.590600E-01 |
| Classical-VS-Normal |
4.161600E-01 |
| Tall-VS-Follicular |
2.162800E-01 |
| Tall-VS-Other |
9.846800E-01 |
| Tall-VS-Normal |
4.129400E-01 |
| Follicular-VS-Other |
6.173800E-01 |
| Follicular-VS-Normal |
6.230400E-01 |
| Other-VS-Normal |
6.641200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.877800E-01 |
| Normal-vs-N1 |
1.271970E-01 |
| N0-vs-N1 |
9.937800E-03 |
|
|
